These rare variants, like nearly all of those found in KCNQ2 encephalopathy, cause clinical symptoms in heterozygous individuals, so the observed effects on CaM binding and protein expression may not contribute to clinical severity. Here, KCNQ2 is linked to Encephalopathy.